Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

7.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating Spatial and Morphological Characteristics into Melanoma Prognosis: A Computational Approach.

Cancers·2024
Same author

Reconstruction based on adaptive group least angle regression for fluorescence molecular tomography.

Biomedical optics express·2023
Same author

A Fast and Automated FMT/XCT Reconstruction Strategy Based on Standardized Imaging Space.

IEEE transactions on medical imaging·2021
Same author

A Novel Adaptive Parameter Search Elastic Net Method for Fluorescent Molecular Tomography.

IEEE transactions on medical imaging·2021
Same author

Curdlan blocks the immune suppression by myeloid-derived suppressor cells and reduces tumor burden.

Immunologic research·2016
Same author

Combined image guided monitoring the pharmacokinetics of rapamycin loaded human serum albumin nanoparticles with a split luciferase reporter.

Nanoscale·2016

Related Experiment Video

Updated: Nov 7, 2025

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

5.0K

ImmunoAIzer: A Deep Learning-Based Computational Framework to Characterize Cell Distribution and Gene Mutation in

Chang Bian1,2, Yu Wang1,2, Zhihao Lu3

  • 1CAS Key Laboratory of Molecular Imaging, The State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China.

Cancers
|April 30, 2021
PubMed
Summary

A new AI tool, ImmunoAIzer, accurately predicts immune cell distribution and detects gene mutations in colon cancer. This computational framework aids in guiding cancer immunotherapy and improving patient prognoses.

Keywords:
biomarkercell distributiondeep learninghematoxylin and eosin (H&E)semi-supervised learningtumor gene mutationtumor microenvironment (TME)

More Related Videos

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.2K
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.4K

Related Experiment Videos

Last Updated: Nov 7, 2025

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

5.0K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.2K
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.4K

Area of Science:

  • Computational pathology
  • Cancer immunotherapy
  • Bioinformatics

Background:

  • Accurate spatial distribution of tumor-infiltrating lymphocytes (TILs) and cancer cells within the tumor microenvironment (TME) is crucial for cancer immunotherapy and prognosis.
  • Tumor gene mutation status also significantly impacts treatment strategies and patient outcomes.
  • Current methods for analyzing these factors can be time-consuming and costly.

Purpose of the Study:

  • To develop a deep learning-based computational framework, ImmunoAIzer, for analyzing the tumor microenvironment and predicting gene mutation status.
  • To provide an efficient and cost-effective tool for guiding cancer immunotherapy and improving prognoses.
  • To assess the generalizability of the framework for potential application in other cancer types.

Main Methods:

  • Implemented a semi-supervised strategy to train a cellular biomarker distribution prediction network (CBDPN).
  • CBDPN predicted spatial distributions of CD3, CD20, PanCK, and DAPI biomarkers with 90.4% accuracy.
  • Utilized CBDPN to identify tumor regions on H&E slides for training a multilabel tumor gene mutation detection network (TGMDN).
  • TGMDN detected APC, KRAS, and TP53 mutations with AUC values of 0.76, 0.77, and 0.79, respectively.

Main Results:

  • The CBDPN achieved high accuracy in predicting biomarker spatial distributions within the TME.
  • The TGMDN demonstrated significant capability in detecting key tumor gene mutations.
  • ImmunoAIzer efficiently integrates spatial cell distribution and mutation status analysis.

Conclusions:

  • ImmunoAIzer offers a comprehensive and cost-effective approach to analyze colon cancer patients' TME and mutation status.
  • The framework serves as a valuable auxiliary tool for guiding immunotherapy and predicting prognoses.
  • The ImmunoAIzer method is generalizable and shows potential for broader application in oncology.